89 related articles for article (PubMed ID: 958587)
1. [Treatment of parkinsonism with dopaminergic system agonists].
Dowzenko A
Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587
[No Abstract] [Full Text] [Related]
2. Clinical studies with bromocriptine in idiopathic parkinsonism.
Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
[No Abstract] [Full Text] [Related]
3. Letter: Bromocriptine in parkinsonism.
Debono AG; Donaldson I; Marsden CD; Parkes JD
Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
[No Abstract] [Full Text] [Related]
4. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Kissel P; Andre JM; Jacquier A
Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
[No Abstract] [Full Text] [Related]
5. Bromocriptine in the treatment of parkinsonism.
Parkes JD
Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
[TBL] [Abstract][Full Text] [Related]
6. Treatment of parkinsonism with bromocriptine.
Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
[No Abstract] [Full Text] [Related]
7. Letter: Bromocriptine in parkinsonism.
Lees AJ; Shaw KM; Stern GM
Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
[No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
9. Developments in the treatment of parkinsonism.
Calne DB
N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
[No Abstract] [Full Text] [Related]
10. [Dopaminergic agonists in Parkinson disease].
Dubois B; Agid Y
Rev Prat; 1986 Jan; 36(5):207-14. PubMed ID: 3961400
[No Abstract] [Full Text] [Related]
11. Progress in the pharmacotherapy of Parkinsonism.
Calne DB; Eisler T; Gopinathan G; Williams A
Adv Biochem Psychopharmacol; 1980; 23():237-43. PubMed ID: 6104907
[No Abstract] [Full Text] [Related]
12. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
13. Dopamine agonists as primary treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
[No Abstract] [Full Text] [Related]
14. Treatment of parkinsonism.
Calne DB; Teychenne PF; Pfeiffer RF
Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
[No Abstract] [Full Text] [Related]
15. Letter: Growth-hormone response to bromocriptine in parkinsonism.
Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
[No Abstract] [Full Text] [Related]
16. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
Jackson JA; Jankovic J; Ford J
Ann Neurol; 1983 Mar; 13(3):273-8. PubMed ID: 6847139
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
Ludin HP; Kunz F; Lörincz P; Ringwald E
Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
[No Abstract] [Full Text] [Related]
18. Ergot derivatives for Parkinsonism.
Calne DB; Williams AC; Nutt JG; Neophytides A; Eisler T; Teychenne PF
Med J Aust; 1978 Nov; 2(3 Suppl):25-6. PubMed ID: 34083
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Parkinson's disease with bromocriptine.
Jotkowitz S
N Engl J Med; 1977 Sep; 297(9):508-9. PubMed ID: 578000
[No Abstract] [Full Text] [Related]
20. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
